Strides Pharma Science, 532531, STAR Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,623.68
21.71
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

10,229.67
0.43%
3.25

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.78
6.60
7.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.68
4.94
15.67

PAT CAGR (%)

10 Years
5 Years
3 Years

13.60
2.84
132.95

P:E (Median)

8 Years
5 Years
3 Years

5.95
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.20
2.50
2.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.78
16.09
12.44

Earnings Forecasts:

(Updated: 01-11-2025)

Description 2024 2025 2026 2027
Adj EPS 390.55 51.9 67.8
P/E Ratio 2.39 18.01 13.79
Revenue 4565.33 5075.4 5687.5
EBITDA 802.81 953.7 1100.6
Net Income 3593.45 478.7 624.7
ROA 60.45
P/B Ratio 3.38 2.86 2.43
ROE 153.65 17.1 19.1
FCFF 216.8 490.8 622.9
FCFF Yield 2.36 5.35 6.79
Net Debt 1673.35
BVPS 276.88 326.58 384.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 522.15 519.55 0.50% 498.62 513.00 -2.80% 555.96 602.95 -7.79% 550.92 379.64 45.12%
Expenses 459.93 464.18 -0.92% 431.39 447.95 -3.70% 488.03 491.53 -0.71% 476.82 378.17 26.09%
EBITDA 62.22 55.37 12.37% 67.23 65.05 3.35% 67.93 111.42 -39.03% 74.10 1.47 4,940.82%
EBIDTM 11.92% 10.66% 13.48% 12.68% 12.22% 18.48% 13.45% 0.39%
Other Income 14.09 23.55 -40.17% 1.76 8.09 -78.24% 12.12 25.65 -52.75% 2.43 4.90 -50.41%
Interest 29.41 41.83 -29.69% 30.45 40.51 -24.83% 29.36 39.05 -24.81% 34.21 36.24 -5.60%
Depreciation 21.51 20.70 3.91% 22.14 20.62 7.37% 22.37 21.92 2.05% 20.92 21.52 -2.79%
PBT 25.39 16.38 55.01% 16.40 12.00 36.67% 28.32 76.02 -62.75% 21.38 -56.69 -
Tax -6.65 -0.88 - 3.06 1.17 161.54% 12.20 -2.83 - 6.44 3.60 78.89%
PAT 32.04 17.26 85.63% 13.35 10.83 23.27% 16.13 78.84 -79.54% 14.94 -60.29 -
PATM 6.14% 3.32% 2.68% 2.11% 2.90% 13.08% 2.71% -15.88%
EPS 3.48 1.87 86.10% 1.45 1.18 22.88% 1.75 8.55 -79.53% 1.62 -6.54 -

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 1,220.83 1,166.93 4.62% 1,119.74 1,054.34 6.20% 1,190.39 1,043.50 14.08% 1,153.67 1,005.77 14.71%
Expenses 989.26 982.33 0.71% 901.66 864.31 4.32% 972.52 839.19 15.89% 943.35 863.78 9.21%
EBITDA 231.57 184.60 25.44% 218.07 190.03 14.76% 217.87 204.31 6.64% 210.31 141.99 48.12%
EBIDTM 18.97% 15.82% 19.48% 18.02% 18.30% 19.58% 18.23% 14.12%
Other Income 27.14 28.41 -4.47% 8.58 12.72 -32.55% 11.98 -13.55 - 5.62 8.75 -35.77%
Interest 46.13 73.82 -37.51% 47.46 72.52 -34.56% 50.32 71.10 -29.23% 52.18 69.71 -25.15%
Depreciation 49.64 48.45 2.46% 48.89 46.52 5.09% 48.86 47.94 1.92% 48.42 49.44 -2.06%
PBT 154.17 86.87 77.47% 121.94 182.07 -33.03% 103.25 63.66 62.19% 112.89 21.52 424.58%
Tax 21.59 13.94 54.88% 16.45 19.02 -13.51% 20.76 12.52 65.81% 23.80 15.74 51.21%
PAT 132.57 72.93 81.78% 105.49 163.06 -35.31% 82.49 51.14 61.30% 89.09 5.78 1,441.35%
PATM 10.86% 6.25% 9.42% 15.47% 6.93% 4.90% 7.72% 0.57%
EPS 13.84 7.81 77.21% 10.81 364.62 -97.04% 8.92 1.98 350.51% 9.54 5.41 76.34%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,127.65 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44 1,955.40 1,381.82 2,221.63 Net Sales Growth 5.58% 14.65% 0.63% -6.29% 6.54% 9.79% 10.05% -21.37% 41.51% -37.80% Cost Of Goods Sold 1,086.02 1,083.54 969.16 1,065.61 1,101.52 988.87 891.96 878.83 781.25 734.46 1,282.09 Gross Profit 1,041.63 1,055.89 896.96 788.89 877.49 868.70 799.97 658.61 1,174.15 647.36 939.55 GP Margin 48.96% 49.35% 48.07% 42.54% 44.34% 46.77% 47.28% 42.84% 60.05% 46.85% 42.29% Total Expenditure 1,856.17 1,888.05 1,724.32 1,771.77 1,902.37 1,698.33 1,487.47 1,403.10 1,815.21 1,269.85 1,953.73 Power & Fuel Cost - 36.00 47.90 45.54 43.76 45.82 44.53 39.77 33.08 25.82 74.12 % Of Sales - 1.68% 2.57% 2.46% 2.21% 2.47% 2.63% 2.59% 1.69% 1.87% 3.34% Employee Cost - 377.59 348.92 267.01 272.09 272.72 230.23 223.21 224.53 228.48 274.16 % Of Sales - 17.65% 18.70% 14.40% 13.75% 14.68% 13.61% 14.52% 11.48% 16.53% 12.34% Manufacturing Exp. - 191.36 196.84 189.99 151.87 153.93 140.73 121.12 106.78 108.28 103.48 % Of Sales - 8.94% 10.55% 10.24% 7.67% 8.29% 8.32% 7.88% 5.46% 7.84% 4.66% General & Admin Exp. - 89.19 62.35 84.63 136.15 115.41 120.08 74.99 79.18 80.46 111.16 % Of Sales - 4.17% 3.34% 4.56% 6.88% 6.21% 7.10% 4.88% 4.05% 5.82% 5.00% Selling & Distn. Exp. - 98.49 75.99 98.01 177.44 94.08 21.02 24.40 26.53 27.80 75.28 % Of Sales - 4.60% 4.07% 5.28% 8.97% 5.06% 1.24% 1.59% 1.36% 2.01% 3.39% Miscellaneous Exp. - 11.90 23.17 20.99 19.55 27.50 38.91 40.78 563.85 64.55 75.28 % Of Sales - 0.56% 1.24% 1.13% 0.99% 1.48% 2.30% 2.65% 28.84% 4.67% 1.51% EBITDA 271.48 251.37 141.80 82.73 76.63 159.24 204.46 134.34 140.19 111.97 267.90 EBITDA Margin 12.76% 11.75% 7.60% 4.46% 3.87% 8.57% 12.08% 8.74% 7.17% 8.10% 12.06% Other Income 30.40 57.26 67.42 99.82 123.48 117.08 93.07 114.61 1,001.72 169.06 109.12 Interest 123.43 145.91 139.38 138.68 74.24 65.34 66.84 54.09 81.97 71.96 102.62 Depreciation 86.94 84.61 87.41 93.62 104.37 99.34 94.24 83.00 114.77 70.01 102.69 PBT 91.49 78.11 -17.57 -49.76 21.51 111.64 136.44 111.85 945.18 139.06 171.70 Tax 15.05 18.93 1.34 -69.44 -158.68 33.40 16.17 -2.04 24.21 15.36 14.71 Tax Rate 16.45% 24.24% -5.84% 107.23% -737.70% 29.92% 11.85% -1.88% 2.64% 12.40% 10.15% PAT 76.46 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 PAT before Minority Interest 76.46 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.59% 2.77% -1.30% 0.25% 9.11% 4.21% 7.11% 7.18% 45.60% 7.85% 5.86% PAT Growth 63.94% - - -97.40% 130.30% -34.95% 8.98% -87.62% 721.44% -16.64% EPS 8.29 6.42 -2.63 0.51 19.54 8.49 13.05 11.97 96.70 11.77 14.12

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,684.63 4,565.34 3,890.13 3,688.39 3,070.25 3,315.87 2,981.12 3,108.33 3,344.37 3,826.22 2,862.19 Net Sales Growth 9.70% 17.36% 5.47% 20.13% -7.41% 11.23% -4.09% -7.06% -12.59% 33.68% Cost Of Goods Sold 1,938.64 1,979.96 1,749.05 1,626.88 1,502.32 1,332.79 1,122.48 1,085.20 1,378.84 1,281.17 1,502.29 Gross Profit 2,745.99 2,585.37 2,141.07 2,061.50 1,567.93 1,983.08 1,858.64 2,023.14 1,965.53 2,545.05 1,359.90 GP Margin 58.62% 56.63% 55.04% 55.89% 51.07% 59.81% 62.35% 65.09% 58.77% 66.52% 47.51% Total Expenditure 3,806.79 3,767.56 3,317.89 3,303.09 3,091.76 2,689.06 2,470.90 2,811.65 3,108.66 3,309.30 2,481.62 Power & Fuel Cost - 58.17 75.13 85.82 71.54 64.58 64.49 54.39 51.33 33.87 77.18 % Of Sales - 1.27% 1.93% 2.33% 2.33% 1.95% 2.16% 1.75% 1.53% 0.89% 2.70% Employee Cost - 862.76 737.05 732.02 646.91 550.15 442.56 329.44 434.05 419.16 357.69 % Of Sales - 18.90% 18.95% 19.85% 21.07% 16.59% 14.85% 10.60% 12.98% 10.95% 12.50% Manufacturing Exp. - 311.98 299.81 259.45 255.52 237.94 210.79 150.98 115.97 137.47 119.23 % Of Sales - 6.83% 7.71% 7.03% 8.32% 7.18% 7.07% 4.86% 3.47% 3.59% 4.17% General & Admin Exp. - 221.56 198.06 232.21 223.67 191.73 191.89 150.10 194.38 172.63 198.71 % Of Sales - 4.85% 5.09% 6.30% 7.29% 5.78% 6.44% 4.83% 5.81% 4.51% 6.94% Selling & Distn. Exp. - 298.20 215.03 263.65 331.30 223.22 137.07 111.22 208.85 161.12 129.57 % Of Sales - 6.53% 5.53% 7.15% 10.79% 6.73% 4.60% 3.58% 6.24% 4.21% 4.53% Miscellaneous Exp. - 34.93 43.76 103.06 60.51 88.65 301.61 930.33 725.25 1,103.88 129.57 % Of Sales - 0.77% 1.12% 2.79% 1.97% 2.67% 10.12% 29.93% 21.69% 28.85% 3.39% EBITDA 877.82 797.78 572.24 385.30 -21.51 626.81 510.22 296.68 235.71 516.92 380.57 EBITDA Margin 18.74% 17.47% 14.71% 10.45% -0.70% 18.90% 17.12% 9.54% 7.05% 13.51% 13.30% Other Income 53.32 63.76 49.85 135.22 133.40 59.44 66.70 322.90 920.64 398.08 102.37 Interest 196.09 248.85 280.22 261.14 176.74 150.06 155.72 79.29 196.24 183.10 168.17 Depreciation 195.81 192.26 213.64 243.25 233.01 206.29 187.79 171.85 193.93 198.69 131.25 PBT 492.25 420.42 128.22 16.11 -297.88 329.90 233.42 368.44 766.17 533.20 183.50 Tax 82.60 77.52 29.11 -55.30 -178.26 31.65 17.91 14.49 21.41 51.19 42.45 Tax Rate 16.78% 15.98% -47.86% 6010.87% 32.91% 8.48% 11.50% 3.71% 2.96% 10.30% 29.87% PAT 409.64 405.34 -120.20 -221.20 -460.21 352.32 143.62 370.31 681.31 399.38 113.21 PAT before Minority Interest 394.15 409.40 -143.90 -230.90 -474.25 341.61 137.82 375.57 701.18 445.58 99.68 Minority Interest -15.49 -4.06 23.70 9.70 14.04 10.71 5.80 -5.26 -19.87 -46.20 13.53 PAT Margin 8.74% 8.88% -3.09% -6.00% -14.99% 10.63% 4.82% 11.91% 20.37% 10.44% 3.96% PAT Growth 39.85% - - - - 145.31% -61.22% -45.65% 70.59% 252.78% EPS 44.43 43.96 -13.04 -23.99 -49.91 38.21 15.58 40.16 73.89 43.32 12.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,192.74 3,527.60 3,455.05 3,406.68 3,248.06 3,158.79 3,256.80 3,162.02 3,232.53 3,157.63 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 3,100.06 3,432.61 3,345.33 3,314.44 3,153.66 3,063.50 3,159.68 3,063.45 3,134.25 3,062.51 Non-Current Liabilities 108.36 170.19 272.63 108.27 307.43 -37.31 -63.12 -34.41 795.22 876.55 Secured Loans 127.37 202.32 284.74 124.69 147.54 0.00 0.15 2.44 769.45 861.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 51.68 46.34 33.32 33.47 207.17 20.58 12.88 13.32 22.58 10.14 Current Liabilities 1,629.61 2,085.14 1,796.83 1,841.32 1,590.64 1,454.94 1,388.99 1,104.05 1,434.15 1,244.88 Trade Payables 484.85 543.76 643.44 643.80 735.20 489.87 509.40 390.72 470.56 497.17 Other Current Liabilities 169.73 236.78 153.81 108.43 136.11 93.08 49.36 73.51 290.27 195.69 Short Term Borrowings 951.93 1,284.28 984.57 1,068.64 693.50 852.45 808.80 601.59 647.44 543.38 Short Term Provisions 23.10 20.33 15.00 20.45 25.82 19.54 21.44 38.22 25.87 8.65 Total Liabilities 4,930.71 5,782.93 5,524.51 5,356.27 5,146.13 4,576.42 4,582.67 4,231.66 5,461.90 5,279.06 Net Block 756.02 735.60 584.30 604.09 576.66 578.35 496.73 497.96 1,123.76 983.58 Gross Block 1,479.95 1,446.15 1,182.95 1,128.61 1,012.07 923.74 746.47 676.58 1,339.89 1,080.89 Accumulated Depreciation 723.93 710.55 598.65 524.52 435.41 345.39 249.74 178.62 216.13 97.31 Non Current Assets 2,785.21 3,371.76 3,398.10 3,381.03 3,402.26 3,180.89 2,919.09 2,732.11 2,882.74 2,633.43 Capital Work in Progress 105.68 107.48 55.38 55.72 110.67 112.25 122.46 143.86 157.75 180.09 Non Current Investment 1,847.69 2,363.59 2,491.77 2,399.76 2,462.48 2,242.91 2,071.47 1,531.19 1,310.77 1,307.94 Long Term Loans & Adv. 50.88 145.96 245.47 304.95 247.32 237.29 223.27 154.76 204.04 154.66 Other Non Current Assets 14.02 7.52 8.92 3.70 5.13 10.10 5.16 404.35 86.41 7.16 Current Assets 2,145.50 2,411.18 2,126.40 1,975.25 1,743.86 1,395.53 1,663.59 1,499.54 2,579.16 2,645.62 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 154.29 311.48 1,279.54 1,139.10 Inventories 431.71 498.07 490.76 513.06 689.08 462.82 473.34 269.63 409.53 379.23 Sundry Debtors 1,452.93 1,565.04 1,307.78 1,296.32 821.66 655.61 582.56 449.37 540.68 692.40 Cash & Bank 30.50 115.10 85.58 14.45 73.04 109.90 180.81 79.79 94.92 94.34 Other Current Assets 230.36 126.51 92.60 83.67 160.07 167.20 272.58 389.29 254.49 340.55 Short Term Loans & Adv. 118.76 106.46 149.68 67.75 80.42 89.14 123.06 175.88 122.37 95.54 Net Current Assets 515.89 326.04 329.58 133.92 153.22 -59.42 274.59 395.49 1,145.00 1,400.74 Total Assets 4,930.71 5,782.94 5,524.50 5,356.28 5,146.12 4,576.42 4,582.68 4,231.65 5,461.90 5,279.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,551.83 2,125.57 2,212.26 2,359.23 2,776.66 2,527.42 2,648.70 2,463.66 2,748.82 2,657.87 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 2,459.16 2,030.57 2,102.54 2,266.99 2,682.26 2,432.13 2,551.59 2,365.10 2,650.55 2,562.75 Non-Current Liabilities 601.61 621.44 1,210.30 965.72 1,264.45 813.65 2,342.88 2,067.29 2,048.67 2,760.03 Secured Loans 558.47 618.40 1,040.81 744.86 873.43 601.79 1,806.45 1,551.09 1,622.87 2,614.88 Unsecured Loans 12.78 53.10 98.98 90.77 9.15 2.12 0.06 0.23 14.84 12.13 Long Term Provisions 113.94 91.63 73.42 64.28 246.50 63.95 52.24 16.55 25.19 14.45 Current Liabilities 2,591.52 2,879.26 2,990.20 3,411.68 2,738.35 2,544.86 2,662.24 1,899.30 3,103.87 1,891.98 Trade Payables 1,032.50 851.59 982.34 1,071.52 1,134.20 797.75 888.99 712.07 774.09 775.40 Other Current Liabilities 307.41 341.57 527.89 697.18 421.00 354.49 248.12 129.98 819.08 347.93 Short Term Borrowings 1,136.36 1,574.15 1,330.76 1,496.53 1,023.84 1,228.78 1,339.02 944.39 1,393.96 700.48 Short Term Provisions 115.25 111.94 149.20 146.43 159.31 163.84 186.11 112.86 116.73 68.19 Total Liabilities 5,779.59 5,572.41 6,373.38 6,760.72 6,816.80 5,953.17 7,806.77 6,584.90 8,034.86 7,360.09 Net Block 1,888.12 1,853.18 2,298.42 2,333.45 2,151.13 2,025.85 3,570.13 2,903.00 2,909.03 2,678.68 Gross Block 2,897.25 2,873.18 3,324.82 3,231.69 2,841.28 2,534.38 4,049.05 3,229.03 3,186.12 2,825.43 Accumulated Depreciation 1,009.14 1,020.00 1,026.40 898.24 690.15 508.53 478.92 326.03 277.09 146.75 Non Current Assets 2,680.68 2,603.41 3,130.03 3,398.88 3,999.57 3,581.05 4,758.05 4,101.31 4,243.05 3,845.20 Capital Work in Progress 206.76 161.89 150.98 291.08 447.37 412.95 453.03 620.29 780.18 814.88 Non Current Investment 339.71 196.93 438.96 540.34 666.23 503.24 494.34 350.08 315.66 127.19 Long Term Loans & Adv. 140.19 256.13 217.18 210.58 185.80 210.82 223.69 197.22 222.56 201.83 Other Non Current Assets 94.73 123.38 11.91 10.26 549.04 428.19 16.86 30.72 15.62 22.62 Current Assets 3,098.91 2,969.00 3,135.25 3,361.83 2,817.23 2,372.11 3,048.72 2,483.59 3,791.82 3,514.89 Current Investments 69.50 105.76 50.84 0.00 99.41 118.97 284.75 311.48 1,279.54 1,213.76 Inventories 1,277.57 1,126.24 1,146.51 1,173.80 1,200.70 782.54 874.16 552.02 732.80 613.14 Sundry Debtors 1,202.94 1,141.87 1,299.40 1,207.30 1,110.59 931.69 987.18 882.18 995.91 1,032.97 Cash & Bank 136.78 191.17 315.96 187.35 179.76 237.10 516.65 303.33 329.48 311.59 Other Current Assets 412.12 228.99 169.21 647.90 226.76 301.81 385.98 434.59 454.09 343.44 Short Term Loans & Adv. 135.92 174.97 153.34 145.49 128.54 218.24 249.11 295.75 244.39 97.54 Net Current Assets 507.39 89.74 145.05 -49.84 78.89 -172.75 386.48 584.29 687.95 1,622.91 Total Assets 5,779.59 5,572.41 6,265.28 6,760.71 6,816.80 5,953.16 7,806.77 6,584.90 8,034.87 7,360.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 421.48 -14.01 241.74 -282.69 282.76 137.63 39.97 65.59 411.74 83.08 PBT 2,905.14 40.99 -64.76 21.51 111.64 136.44 108.33 915.80 123.90 144.91 Adjustment -2,622.75 250.90 172.87 75.17 114.15 130.28 90.19 -670.77 193.49 156.46 Changes in Working Capital 16.58 -359.60 33.81 -400.77 -109.81 -96.91 -121.04 -161.75 131.16 -168.93 Cash after chg. in Working capital 298.97 -67.71 141.92 -304.09 115.97 169.81 77.48 83.28 448.55 132.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 122.52 53.71 99.82 21.41 166.79 -32.17 -37.52 -17.68 -36.81 -49.36 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -137.59 -69.56 -182.58 18.78 -275.64 62.83 -166.06 447.36 -344.05 -1,063.90 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -621.49 117.56 -36.57 17.65 30.68 247.04 265.52 -977.48 35.88 950.61 Cash from Financing Activity -370.32 93.34 10.82 250.73 -48.64 -203.56 123.26 -706.77 -67.24 1,570.84 Net Cash Inflow / Outflow -86.42 9.77 69.98 -13.18 -41.52 -3.09 -2.83 -193.82 0.45 590.03 Opening Cash & Equivalents 92.75 82.11 12.12 25.30 66.82 69.91 72.30 280.52 818.84 264.05 Closing Cash & Equivalent 6.33 92.75 82.11 12.12 25.30 66.82 69.47 72.30 280.52 818.84

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 684.37 701.07 44.41 -257.81 481.44 204.79 60.05 187.07 288.14 73.25 PBT 3,675.03 -62.72 -267.63 -652.51 289.38 48.51 344.37 705.80 497.14 146.44 Adjustment -2,893.97 818.27 682.19 582.27 363.31 527.49 94.59 -274.51 190.92 345.56 Changes in Working Capital -163.72 -78.73 -457.80 -189.90 -328.05 -326.23 -323.14 -190.66 -341.30 -341.71 Cash after chg. in Working capital 617.34 676.82 -43.23 -260.14 324.64 249.76 115.82 240.63 346.76 150.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 67.04 24.25 87.64 2.33 156.80 -44.98 -55.76 -53.56 -58.62 -77.04 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -89.69 -150.25 302.47 -118.73 -520.82 1,306.16 -148.49 582.59 -686.69 -2,224.83 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -573.59 36.87 448.48 -119.86 -214.50 1,490.37 283.09 -842.25 -306.76 -210.32 Cash from Financing Activity -642.58 -693.32 -213.92 421.32 -15.80 -1,709.45 194.27 -1,015.69 338.21 2,943.94 Net Cash Inflow / Outflow -47.90 -142.51 132.96 44.77 -55.18 -198.50 105.83 -246.03 -60.33 792.35 Opening Cash & Equivalents 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74 298.91 Closing Cash & Equivalent 112.56 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 346.37 383.52 380.46 379.13 361.65 352.04 362.84 352.29 360.50 352.77 ROA 1.10% -0.43% 0.09% 3.43% 1.61% 2.63% 2.50% 18.40% 2.02% 2.98% ROE 1.76% -0.70% 0.14% 5.42% 2.45% 3.76% 3.45% 27.96% 3.40% 5.63% ROCE 4.71% 2.34% 1.56% 2.18% 4.35% 5.03% 4.15% 23.18% 4.10% 7.52% Fixed Asset Turnover 1.46 1.42 1.60 1.85 1.92 2.03 2.16 1.94 1.14 2.51 Receivable days 257.44 280.95 256.27 195.32 145.14 133.56 122.49 92.40 162.86 77.91 Inventory Days 79.31 96.70 98.79 110.86 113.17 100.98 88.19 63.39 104.17 43.92 Payable days 173.25 223.56 220.46 228.47 226.09 127.51 117.56 116.72 143.54 64.74 Cash Conversion Cycle 163.51 154.10 134.60 77.70 32.22 107.02 93.13 39.07 123.49 57.08 Total Debt/Equity 0.36 0.46 0.39 0.37 0.27 0.27 0.25 0.19 0.50 0.49 Interest Cover 1.54 0.84 0.53 1.29 2.71 3.04 3.00 12.17 2.72 2.41

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 276.83 230.95 242.83 262.48 309.09 281.55 294.94 274.26 306.41 296.83 ROA 7.21% -2.41% -3.52% -6.99% 5.35% 2.00% 5.22% 9.59% 5.79% 2.03% ROE 17.52% -6.67% -10.15% -18.49% 12.91% 5.34% 14.74% 27.00% 16.53% 5.25% ROCE 16.56% 3.47% -0.49% -9.49% 11.17% 6.01% 8.65% 16.07% 10.75% 7.54% Fixed Asset Turnover 2.46 1.96 1.91 1.75 2.04 1.50 1.17 1.04 1.27 1.47 Receivable days 60.35 73.17 73.25 79.41 68.09 70.88 79.95 102.49 96.77 90.73 Inventory Days 61.86 68.12 67.80 81.35 66.13 61.20 61.00 70.11 64.20 52.34 Payable days 173.66 191.36 230.40 267.95 264.54 138.58 146.59 116.23 117.33 75.51 Cash Conversion Cycle -51.45 -50.07 -89.35 -107.20 -130.32 -6.50 -5.64 56.37 43.64 67.55 Total Debt/Equity 0.70 1.14 1.27 1.18 0.76 0.78 1.22 1.03 1.35 1.34 Interest Cover 2.96 0.59 -0.10 -2.69 3.49 2.00 5.92 4.68 3.71 1.85

Top Investors:

quant mutual fund - quant multi cap fund

route one offshore master fund, l.p.

sbi life insurance co. ltd

route one fund i, l.p.

morgan stanley asia (singapore) pte. - odi

satpal khattar

authum investment and infrastructure limited

axis mutual fund trustee ltd a/c axis mutual fund

mukul mahavir agrawal

oman india joint investment fund ii

Annual Reports:

News Update:

Strides Pharma Scien - Quarterly Results
1st Nov 2025, 00:00 AM

Read More
Strides Pharma Science’s arm enters into strategic product development partnership with Kenox
9th Sep 2025, 09:17 AM

Strides will collaborate with Kenox on the development and filing of multiple nasal spray products for the US market across diverse therapeutic indications
Read More

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532531 | NSE: STAR

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532531 | NSE: STAR

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: